Normunity
PrivateLast Round
Series B
Jan 13, 2025
Est. Valuation
$500M
Total Funding Raised
$140M
Company Overview
Normunity is a biotechnology company that develops precision immuno-oncology therapies designed to restore the immune system's natural ability to identify and eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Normunity Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Normunity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Oct 25, 2022 |
Key People
Founding team and executive leadership
Normunity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Connecticut Innovations | Series B |
| Taiho Ventures | Series B, Series A |
| Osage University Partners | Series B, Series A |
| HongShan | Series B |
| Canaan Partners | Series B, Series A |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2026
Will participate in the TD Cowen 46th Annual Health Care Conference.
- Jan 13, 2025
$75M round with a $500M post-money valuation.
Normunity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Normunity's valuation, stock price, and market status.